GlassScriptPhysician profile
Richard A Silva
NPI 1952309635
$2,183.80
in general payments reported to CMS, 2019-2025
29 companies · $383 in 2025
The $383 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $110 · 2021: $136 · 2022: $386 · 2023: $320 · 2024: $542 · 2025: $383.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,245.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $410.37 | 2023-2025 | Varithena Administration Pack, General - Vascular Intervention, General - Thrombectomy |
| W. L. Gore & Associates, INC. | $296.29 | 2019-2025 | Gore Viabahn Endoprosthesis With Heparin |
| Abbott Laboratories | $219.18 | 2019-2025 | Esprit, Absolute Pro |
| Medtronic, INC. | $205.62 | 2021-2023 | Arctic Front Advance |
| Bard Peripheral Vascular, INC. | $129.18 | 2019-2024 | Venclose Maven Catheter, Venovo, Denali Vena Cava Filter |
| Tactile Systems Technology INC | $117.73 | 2019-2024 | Entre Plus, Flexitouch Plus |
| E.R. Squibb & Sons, L.L.C. | $92.80 | 2019-2023 | Camzyos |
| Nevro Corp. | $75.58 | 2024 | Senza |
| Janssen Pharmaceuticals, INC | $72.45 | 2019-2024 | Xarelto |
| Becton, Dickinson and Company | $68.86 | 2024 | Venclose Maven Catheter, Venovo |
| Silk Road Medical, INC. | $65.90 | 2020 | |
| Smith+Nephew, INC. | $44.68 | 2019-2020 | |
| Angiodynamics, INC. | $44.37 | 2022 | |
| Okami Medical, INC. | $33.56 | 2025 | Lobo |
| Inari Medical, INC. | $29.82 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $26.15 | 2019 | |
| Kerecis Limited | $25.58 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Argon Medical Devices, INC. | $24.62 | 2024 | Retrieval Kit |
| Pfizer INC. | $23.90 | 2019 | |
| Cardiovascular Systems INC. | $23.29 | 2020-2022 | |
| Axogen | $20.07 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Stryker Corporation | $19.81 | 2025 | Revcore Thrombectomy Catheter |
| Sirtex Medical INC | $19.76 | 2025 | Lava Les (Liquid Embolic System) |
| Normatec Industries, LP | $19.56 | 2019 | |
| Alexion Pharmaceuticals, INC. | $17.27 | 2023 | Ultomiris |
| Cook Medical LLC | $16.92 | 2024 | Rosen |
| Lemaitre Vascular, INC. | $14.43 | 2022 | |
| Bolton Medical INC | $14.00 | 2022 | |
| Surmodics, INC. | $12.05 | 2023 | Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime 014 Rx Pta Balloon Dilatation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Silva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.